TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Klaria Pharma Holding AB (publ)
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover | 0 | 5,551 | 0 |
Financial expenses | 3,833 | 8,216 | 3,352 |
Earnings before taxes | -18,682 | -60,214 | -52,218 |
EBITDA | -14,856 | -52,001 | -48,867 |
Total assets | 73,899 | 113,766 | 115,378 |
Current assets | 73,871 | 38,554 | 27,114 |
Current liabilities | 32,229 | 41,476 | 46,688 |
Equity capital | 41,668 | 71,964 | 67,693 |
- share capital | 1,798 | 1,235 | 842 |
Employees (average) | 7 | 8 | 6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency | 56.4% | 63.3% | 58.7% |
Turnover per employee | 0 | 694 | 0 |
Profit as a percentage of turnover | -1084.7% | ||
Return on assets (ROA) | -20.1% | -45.7% | -42.4% |
Current ratio | 229.2% | 93.0% | 58.1% |
Return on equity (ROE) | -44.8% | -83.7% | -77.1% |
Change turnover | -5,944 | 5,551 | 0 |
Change turnover % | -100% | ||
Chg. No. of employees | -1 | 2 | 0 |
Chg. No. of employees % | -13% | 33% | 0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.